REFERENCES
1. Global Burden of Disease Collaborative Network. GBD Results Tool. Institute for Health Metrics and Evaluation (IHME), Seattle, WA, 2024. Available from https://vizhub.healthdata.org/gbd-results/ [accessed 24 June 2026].
2. Lailler G, Grave C, Gabet A, et al. Early mortality, cardiovascular, and renal diseases in women’s lives following hypertensive disorders of pregnancy: the prospective nationwide study CONCEPTION. J Am Heart Assoc. 2024;13:e033252.
3. disease: improving global outcomes (KDIGO) diabetes work group. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2022;102:S1-127.
4. Wang B, Wang N, Yin X, et al. Gestational diabetes mellitus and accelerated biological aging in middle-aged and elderly women. Diabetes Care. 2026;49:317-24.
5. Fan L, Ding L, Nie J, Wang J, Zhang M, Zhang J. Hypertensive disorders of pregnancy: a comprehensive review of pathophysiology, diagnosis, treatment, and long-term cardiovascular implications. Clin Exp Hypertens. 2026;48:2641542.
6. Kramer CK, Campbell S, Retnakaran R. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Diabetologia. 2019;62:905-14.
7. Wambua S, Singh M, Okoth K, et al.; MuM-PreDiCT Group. Association between pregnancy-related complications and development of type 2 diabetes and hypertension in women: an umbrella review. BMC Med. 2024;22:66.
8. Christensen MH, Bistrup C, Rubin KH, et al. Kidney disease in women with previous gestational diabetes mellitus: a nationwide register-based cohort study. Diabetes Care. 2024;47:401-8.
9. Piccoli GB, Torreggiani M, Schwotzer N, et al. Kidney health outcomes of hypertensive disorders of pregnancy. Nat Rev Nephrol. 2025;21:671-86.
10. Shapiro J, Ray JG, McArthur E, et al. Risk of acute kidney injury after hypertensive disorders of pregnancy: a population-based cohort study. Am J Kidney Dis. 2022;79:561-9.
11. Hamill M, Gomez Fernandez C, Mitsigiorgi R, Mansukhani T, Nicolaides KH, Bramham K. Kidney dysfunction following gestational diabetes mellitus. Clin J Am Soc Nephrol. 2025;20:1418-26.
12. Barrett PM, McCarthy FP, Evans M, et al. Hypertensive disorders of pregnancy and the risk of chronic kidney disease: a Swedish registry-based cohort study. PLoS Med. 2020;17:e1003255.
13. Khashan AS, Evans M, Kublickas M, et al. Preeclampsia and risk of end stage kidney disease: a Swedish nationwide cohort study. PLoS Med. 2019;16:e1002875.
14. Ishaku SM, Olanrewaju TO, Browne JL, et al. Prevalence and determinants of chronic kidney disease in women with hypertensive disorders in pregnancy in Nigeria: a cohort study. BMC Nephrol. 2021;22:229.
15. An U, Pazokitoroudi A, Alvarez M, et al. Deep learning-based phenotype imputation on population-scale biobank data increases genetic discoveries. Nat Genet. 2023;55:2269-76.
16. Allen NE, Lacey B, Lawlor DA, et al. Prospective study design and data analysis in UK Biobank. Sci Transl Med. 2024;16:eadf4428.
17. Jiang Y, Zhao B, Wang X, et al. UKB-MDRMF: a multi-disease risk and multimorbidity framework based on UK biobank data. Nat Commun. 2025;16:3767.
18. Heo GY, Koh HB, Park JT, et al. Sweetened beverage intake and incident chronic kidney disease in the UK biobank study. JAMA Netw Open. 2024;7:e2356885.
19. Levey AS, Stevens LA, Schmid CH, et al.; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-12.
20. Inker LA, Schmid CH, Tighiouart H, et al.; CKD-EPI Investigators. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367:20-9.
21. Lamb EJ, MacKenzie F, Stevens PE. How should proteinuria be detected and measured? Ann Clin Biochem. 2009;46:205-17.
22. Townsend P, Phillimore P, Beattie A. Health and deprivation: inequality and the North. 1st ed. Abingdon: Routledge; 2023. Available from: https://www.taylorfrancis.com/books/mono/10.4324/9781003368885/health-deprivation-peter-townsend-peter-phillimore-alastair-beattie. [Last accessed on 8 Jun 2026].
23. Sun Y, Cao D, Zhang Y, et al. Appraising associations between signature lipidomic biomarkers and digestive system cancer risk: novel evidences from a prospective cohort study of UK Biobank and Mendelian randomization analyses. Lipids Health Dis. 2024;23:61.
24. Dehmer EW, Phadnis MA, Gunderson EP, et al. Association between gestational diabetes and incident maternal CKD: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Am J Kidney Dis. 2018;71:112-22.
25. Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12:2032-45.
26. Cortinovis M, Perico N, Ruggenenti P, Remuzzi A, Remuzzi G. Glomerular hyperfiltration. Nat Rev Nephrol. 2022;18:435-51.
27. Rawal S, Olsen SF, Grunnet LG, et al. Gestational diabetes mellitus and renal function: a prospective study with 9- to 16-year follow-up after pregnancy. Diabetes Care. 2018;41:1378-84.
28. Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105:S117-314.
29. Abbate M, Parvanova A, López-González ÁA, et al. MAFLD and glomerular hyperfiltration in subjects with normoglycemia, prediabetes and type 2 diabetes: a cross-sectional population study. Diabetes Metab Res Rev. 2024;40:e3810.
30. Moriconi D. Glomerular hyperfiltration in diabesity: an overlooked target for early intervention. J Nephrol. 2026;39:76-9.
31. Zhang M, Liu WL, Xu G, Dong L. Hyperlipidemia in membranous nephropathy. Clin Kidney J. 2026;19:sfag032.
32. Wuttke M, Li Y, Li M, et al.; Lifelines Cohort Study, V. A. Million Veteran Program. A catalog of genetic loci associated with kidney function from analyses of a million individuals. Nat Genet. 2019;51:957-72.
33. Paauw ND, Joles JA, Drost JT, et al. High-normal estimated glomerular filtration rate in early-onset preeclamptic women 10 years postpartum. Hypertension. 2016;68:1407-14.
34. Tseng ST, Lee MC, Tsai YT, et al. Risks after gestational diabetes mellitus in taiwanese women: a nationwide retrospective cohort study. Biomedicines. 2023;11:2120.
35. Li Z, Cheng Y, Wang D, et al. Incidence rate of type 2 diabetes mellitus after gestational diabetes mellitus: a systematic review and meta-analysis of 170,139 women. J Diabetes Res. 2020;2020:3076463.
36. Sabayev M, Ganio EA, Stelzer IA, et al. Systemic immune dysregulation in hypertensive disorders of pregnancy persists years after delivery. Front Immunol. 2026;17:1716809.
37. Echouffo-Tcheugui JB, Tapia S, Bechraoui-Quantin S, et al. Gestational diabetes mellitus and incident kidney disease: a nationwide french cohort study. Kidney360. 2026;Epub ahead of print.
38. Herman RJ, Ambasta A, Williams RG, et al. Sequential measurement of the neurosensory retina in hypertensive disorders of pregnancy: a model of microvascular injury in hypertensive emergency. J Hum Hypertens. 2023;37:28-35.
